HSU JASON purchased 5.6% of their position (47.70K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $104.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/26/2024ACC: 0001493152-24-052103
+47.70K
Net shares
Net buyer
$104.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
47.70K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.70K
Price / share
$2.17
Trade value
$16.68K
% of position
0.9%
12/20/2024
845.30K→853K
Common Stock
Direct
Shares
+40K
Price / share
$2.19
Trade value
$87.68K
% of position
4.7%
12/23/2024
853K→893K
Total
Net shares
+47.70K
Net value
$104.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2024 | P · Purchase | +7.70K | $2.17 | $16.68K | 0.9% | 845.30K | 853K |
| Common Stock Direct | 12/23/2024 | P · Purchase | +40K | $2.19 | $87.68K | 4.7% | 853K | 893K |
| Total | +47.70K | $104.36K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.92M
Common Stock
IndirectShares owned50K
Total
3.97M indirect3.97M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.92M | Indirect |
| Common Stock | 50K | Indirect |
| Total | 3.97M | 3.97M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported